A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer (NCT06457503)
Single-Arm Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Recurrent Metastatic Nasopharyngeal Carcinoma Systemic Treatment Naïve Participants
🩺 Plain-English Summary (8th-Grade Level)
This study aims to investigate toripalimab with chemotherapy in participants with nasopharyngeal cancer.
Who can join: Review the eligibility criteria below.
Location: University of Arkansas for Medical Sciences — Little Rock, Arkansas
Age range: 12 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (13 Sites)
- University of Arkansas for Medical Sciences — Little Rock, Arkansas
- University of California, Irvine — Irvine, California
- University of California, San Francisco — San Francisco, California
- Emory Winship Cancer Institute — Atlanta, Georgia
- Boston Medical Center — Boston, Massachusetts
- University of Michigan — Ann Arbor, Michigan
- Henry Ford Cancer Center — Detroit, Michigan
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health — New York, New York
- University of Cincinnati Medical Center — Cincinnati, Ohio
- Cleveland Clinic — Cleveland, Ohio
- Penn State Milton S. Hershey Medical Center — Hershey, Pennsylvania
- Froedtert Hospital and the Medical College of Wisconsin — Milwaukee, Wisconsin
- Princess Margaret Cancer Centre — Toronto, Canada
📞 Contact the Study Coordinator
Phone: (800) 794-5434
Email: clinicaltrials@coherus.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Nasopharyngeal Cancer Recurrent clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.